News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

Goldman back on familiar ground with mega M&A win

The Wall Street giant secures sole advisory role of multi-billion dollar healthcare deal, helping it remedy a recent, and rare, rankings slump

Goldman Sachs has moved from an unaccustomed fifth place in the global mergers and acquisitions rankings to second after being appointed as the sole adviser to US healthcare products company Johnson & Johnson on a $20bn-plus takeover.

Johnson & Johnson said in a statement that it had agreed to acquire Synthes, an orthopaedic devices manufacturer for Sfr159 per share, or $21.3bn.

WSJ Logo